191 related articles for article (PubMed ID: 15541756)
1. Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes.
Drobná Z; Waters SB; Walton FS; LeCluyse EL; Thomas DJ; Stýblo M
Toxicol Appl Pharmacol; 2004 Dec; 201(2):166-77. PubMed ID: 15541756
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of arsenic in primary cultures of human and rat hepatocytes.
Styblo M; Del Razo LM; LeCluyse EL; Hamilton GA; Wang C; Cullen WR; Thomas DJ
Chem Res Toxicol; 1999 Jul; 12(7):560-5. PubMed ID: 10409394
[TBL] [Abstract][Full Text] [Related]
3. Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes.
Styblo M; Thomas DJ
Toxicol Appl Pharmacol; 2001 Apr; 172(1):52-61. PubMed ID: 11264023
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of arsenic in human liver: the role of membrane transporters.
Drobná Z; Walton FS; Paul DS; Xing W; Thomas DJ; Stýblo M
Arch Toxicol; 2010 Jan; 84(1):3-16. PubMed ID: 20020104
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.
Vega L; Styblo M; Patterson R; Cullen W; Wang C; Germolec D
Toxicol Appl Pharmacol; 2001 May; 172(3):225-32. PubMed ID: 11312651
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes.
Walton FS; Harmon AW; Paul DS; Drobná Z; Patel YM; Styblo M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):424-33. PubMed ID: 15276423
[TBL] [Abstract][Full Text] [Related]
7. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
Chen GQ; Zhou L; Styblo M; Walton F; Jing Y; Weinberg R; Chen Z; Waxman S
Cancer Res; 2003 Apr; 63(8):1853-9. PubMed ID: 12702573
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.
Drobná Z; Waters SB; Devesa V; Harmon AW; Thomas DJ; Stýblo M
Toxicol Appl Pharmacol; 2005 Sep; 207(2):147-59. PubMed ID: 16102566
[TBL] [Abstract][Full Text] [Related]
9. Interspecies differences in metabolism of arsenic by cultured primary hepatocytes.
Drobná Z; Walton FS; Harmon AW; Thomas DJ; Stýblo M
Toxicol Appl Pharmacol; 2010 May; 245(1):47-56. PubMed ID: 20138079
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes.
Ferrario D; Croera C; Brustio R; Collotta A; Bowe G; Vahter M; Gribaldo L
Toxicology; 2008 Jul; 249(2-3):102-8. PubMed ID: 18524450
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes.
Kedderis GL; Elmore AR; Crecelius EA; Yager JW; Goldsworthy TL
Chem Biol Interact; 2006 Jun; 161(2):139-45. PubMed ID: 16725132
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate.
Kenyon EM; Del Razo LM; Hughes MF
Toxicol Sci; 2005 May; 85(1):468-75. PubMed ID: 15703264
[TBL] [Abstract][Full Text] [Related]
13. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.
Hayakawa T; Kobayashi Y; Cui X; Hirano S
Arch Toxicol; 2005 Apr; 79(4):183-91. PubMed ID: 15526190
[TBL] [Abstract][Full Text] [Related]
14. The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytes.
Mudipalli A; Owen RD; Preston RJ
Int J Oncol; 2005 Sep; 27(3):769-78. PubMed ID: 16077927
[TBL] [Abstract][Full Text] [Related]
15. Selenium compounds modulate the activity of recombinant rat AsIII-methyltransferase and the methylation of arsenite by rat and human hepatocytes.
Walton FS; Waters SB; Jolley SL; LeCluyse EL; Thomas DJ; Styblo M
Chem Res Toxicol; 2003 Mar; 16(3):261-5. PubMed ID: 12641425
[TBL] [Abstract][Full Text] [Related]
16. In vitro methylation of inorganic arsenic in mouse intestinal cecum.
Hall LL; George SE; Kohan MJ; Styblo M; Thomas DJ
Toxicol Appl Pharmacol; 1997 Nov; 147(1):101-9. PubMed ID: 9356312
[TBL] [Abstract][Full Text] [Related]
17. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.
Soto-Reyes E; Del Razo LM; Valverde M; Rojas E
Biometals; 2005 Oct; 18(5):493-506. PubMed ID: 16333750
[TBL] [Abstract][Full Text] [Related]
18. Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects.
Stýblo M; Venkatratnam A; Fry RC; Thomas DJ
Arch Toxicol; 2021 May; 95(5):1547-1572. PubMed ID: 33768354
[TBL] [Abstract][Full Text] [Related]
19. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells.
Naranmandura H; Ogra Y; Iwata K; Lee J; Suzuki KT; Weinfeld M; Le XC
Toxicol Appl Pharmacol; 2009 Jul; 238(2):133-40. PubMed ID: 19442679
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215).
Sakurai T; Kojima C; Kobayashi Y; Hirano S; Sakurai MH; Waalkes MP; Himeno S
Br J Pharmacol; 2006 Dec; 149(7):888-97. PubMed ID: 17043674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
